Page 1755 - Williams Hematology ( PDFDrive )

1730 Part XI: Malignant Lymphoid Diseases Chapter 106: Essential Monoclonal Gammopathy 1731

168. Heriot K, Hallquist AE, Tomar RH: Paraproteinemia in patients with acquired immu- 202. Radl J, VandenBerg A: Transitory appearance of homogeneous immunoglobulins—
nodeficiency syndrome (AIDS) or lymphadenopathy syndrome (LAS). Clin Chem paraproteins—in children with severe combined immunodeficiency before and after
31:1224, 1985. transplantation, in Protides of Biological Fluids, vol 20, edited by Peeters H, p 203. Perga-
169. Kouns DM, Marty AM, Sharpe RW: Oligoclonal bands in serum protein electropho- mon, Oxford, 1973.
retograms of individuals with human immunodeficiency virus antibodies. JAMA 203. Malacrida V, De-Francesco D, Banfi G, et al: Laboratory investigation of monoclonal
256:2343, 1986. gammopathy during 10 years of screening in a general hospital. J Clin Pathol 40:793,
170. Johnston JD, Lumb PJ, Wierzbicki AS: Hyperlipidaemia in association with benign 1987.
paraproteinemia. Ann Clin Biochem 34:697, 1997. 204. DelCarpio J, Espinoza LR, Lauater S, Osterland CK: Transient monoclonal proteins in
171. Papadaki HA, Eliopoulos DG, Ponticoglou C, Eliopoulos GD: Increased frequency of drug hypersensitivity reactions. Am J Med 66:1051, 1979.
monoclonal gammopathy of undetermined significance in patients with nonimmune 205. Keshgegian AA: Prevalence of small monoclonal proteins in the serum of hospitalized
chronic idiopathic neutropenia syndrome. Int J Hematol 73:339, 2001. patients. Am J Clin Pathol 77:436, 1982.
172. Dizdar O, Erman M, Cankurtaran M, et al: Lower bone mineral density in geriatric 206. VanCamp B, Reynaerts PH, Naets JP, Radl J: Transient IgA -λ para-proteinemia during
1
patients with monoclonal gammopathy of undetermined significance. Ann Hematol treatment of acute myeloblastic leukemia. Blood 55:21, 1980.
87:57, 2008. 207. Bakker AJ, Kothman-Tijkotte MJ: Artifactually high concentration of iron determined
173. Tucci A, Bonadonna S, Cattaneo C, et al: Transformation of MGUS to overt multiple in serum from a patient with a monoclonal immunoglobulin. Clin Chem 36:1517, 1990.
myeloma: The possible role of pituitary microadenoma secreting high levels of insulin- 208. Yu A, Pira U: False increase in serum C-reactive protein caused by monoclonal IgM-
like growth factor 1 (IGF-1). Leuk Lymphoma 44:543, 2003. lambda: A case report. Clin Chem Lab Med 39:983, 2001.
174. Chryssikkopoulos A, Dalamaga AL, Hassiakos D: Monoclonal gammopathy of 209. Baz R, Alemany C, Green R, Hussein MA: Prevalence of vitamin B deficiency in
12
unknown significance in pregnancy. Clin Exp Obstet Gynecol 24:31, 1997. patients with plasma cell dyscrasias: A retrospective review. Cancer 101:790, 2004.
175. Buonocore E, Solmon A, Kerley HE: Pseudomyeloma. Radiology 95:41, 1970. 210. Moller-Petersen J, Schmidt EB: Diagnostic value of the concentration of M-component
176. Maldonado JE, Riggs L, Bayrd ED: Pseudomyeloma. Arch Intern Med 135:267, 1975. in initial classification of monoclonal gammopathy. Scand J Haematol 26:295, 1986.
177. Xie Z, Ghosh CC, Patel R, et al: Vascular endothelial hyperpermeability induces the 211. Link H, Kostulas V: Utility of isoelectric focusing of cerebrospinal fluid and serum of
clinical symptoms of Clarkson disease (the systemic capillary leak syndrome). Blood agarose evaluated for neurological patients. Clin Chem 29:810, 1983.
119:4321, 2012. 212. Ouedraogo DE, Makinson A, Vendrell JP, et al: Pivotal role of HIV and EBV replication
178. Kyle RA: Monoclonal gammopathy of unknown significance. Curr Top Microbiol in the long-term persistence of monoclonal gammopathy in patients on antiretroviral
Immunol 210:375, 1996. therapy. Blood 122:3030, 2013.
179. Solomon A: Homogeneous (monoclonal) immunoglobulins in cancer. Am J Med 213. Pham H, Lemoine A, Sol O et al: Monoclonal and oligoclonal gammopathies in liver
63:169, 1977. transplant recipients. Transplantation 58:253, 1994.
180. Colls BM, Lorier MA: Immunocytoma, cancer, and other associations of monoclonal 214. Myara I, Quenum G, Storogenko M, et al: Monoclonal and oligoclonal gammopathies
gammopathy: A review of 224 cases. N Z Med J 82:221, 1975. in heart-transplant recipients. Clin Chem 37:1334, 1991.
181. Abdul M, Hassein NM: Gammopathy associated with advanced prostate cancer. Urol 215. Chiusolo P, Metafuni E, Cattani P, et al: Prospective evaluation of Epstein-Barr virus
Res 23:185, 1995. reactivation after stem cell transplantation: Association with monoclonal gammopathy.
182. Landgren O, Mailankody S: Update on second primary malignancies in multiple mye- J Clin Immunol 30:894, 2010.
loma: A focused review. Leukemia 28:1423, 2014. 216. Ely SA, Knowles DM: Expression of CD56/neural adhesion molecule correlates with
183. Wu SP, Costello R, Hofmann JN, et al: MGUS prevalence in a cohort of AML patients. the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from
Blood 122:294, 2013. monoclonal gammopathy of undetermined significance and lymphomas with plasma-
184. Mailankody S, Pfeiffer RM, Kristinsson SY, et al: Risk of acute myeloid leukemia and cytoid differentiation. Am J Pathol 160:1293, 2002.
myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). 217. San Miguel JF, Caballero MD, Gonzalez M: T-cell subpopulations in patients with
Blood 118:4086, 2011. monoclonal gammopathies: Essential monoclonal gammopathy, multiple myeloma and
185. Shoenfeld Y, Berliner S, Ayalone A, et al: Monoclonal gammopathy in patients with Waldenstrom macroglobulinemia. Am J Hematol 20:267, 1985.
chronic and acute myeloid leukemia. Cancer 54:280, 1984. 218. Lindstrom FD, Hardy WR, Eberle BJ, Williams RC Jr: Multiple myeloma and benign
186. Berner Y, Berrebi A: Myeloproliferative disorders and nonmyelomatous paraprotein. Isr monoclonal gammopathy: Differentiation by immunofluorescence of lymphocytes.
J Med Sci 22:109, 1986. Ann Intern Med 78:837, 1973.
187. Tosato F, Fossaluzza V, Rossi P, et al: Monoclonal gammopathy of undetermined signif- 219. Greipp PR, Kyle RA: Clinical, morphological and cell kinetic differences among multi-
icance in a case of primary thrombocythemia. Haematologica 71:417, 1986. ple myeloma, monoclonal gammopathy of undetermined significance and smoldering
188. Economopoulos T, Economidou J, Papageorgiou E, et al: Monoclonal gammopathy in myeloma. Blood 62:166, 1983.
chronic myeloproliferative disorders. Blut 58:7, 1989. 220. Boccadoro M, Gavarotti P, Fossati G: Low plasma cell 3(H)-thymidine incorporation in
189. Ito T, Kojima H, Otani K, et al: Chronic neutrophilic leukemia associated with mono- MGUS, smoldering myeloma and remission phase myeloma: Reliable identification of
clonal gammopathy of unknown significance. Acta Haematol 95:140, 1996. patients not requiring therapy. Br J Haematol 58:689, 1984.
190. Offit K, Macris NT, Hellman G, Rotterdam, HZ: Consecutive lymphoma with monoclo- 221. Billadeau D, Greipp P, Ahmann G, et al: Detection of B-cells clonally related to the
nal gammopathy in a married couple. Cancer 57:277, 1986. tumor population in multiple myeloma and MGUS. Curr Top Microbiol Immunol 194:9,
191. Venencie PY, Winkelmann RK, Puissant A, Kyle RA: Monoclonal gammopathy in 1995.
Sézary syndrome: Report of three cases and review of the literature. Arch Dermatol 222. Morrell A, Riesen W: Serum β -macroglobulin, serum creatinine and bone marrow
2
120:605, 1984. plasma cells in benign and malignant monoclonal gammopathy. Acta Haematol 64:87,
192. Kamihira S, Taguchi H, Kinoshita K, Ichimaru M: Monoclonal gammopathy in adult 1980.
T-cell leukemia/lymphoma: A report of three cases. Jpn J Clin Oncol 14:699, 1984. 223. Fine JM, Lambin P, Desjobert H: Serum neopterin and β -microglobulin concentra-
2
193. Chisesi I, Capnist G, Barbui T: Two serum IgG M-components of differing light chain tions in monoclonal gammopathies. Acta Med Scand 224:179, 1988.
types in a case of Hodgkin’s disease. Acta Haematol 55:250, 1976. 224. Pasqualetti P, Festucci V, Collacciani A, Casale R: The natural history of monoclonal
194. Hammarstrom L, Smith CIE: Frequent occurrence of monoclonal gammopathies with gammopathy of undetermined significance. Acta Haematol 97:174, 1997.
an imbalanced light-chain ratio following bone marrow transplantation. Transplanta- 225. Gregersen H, Ibsen JS, Mellemkjaer L, et al: Mortality and causes of death in patients
tion 43:447, 1987. with monoclonal gammopathy of undetermined significance. Br J Haematol 112:353,
195. Mitus AJ, Stein R, Rappeport JM, et al: Monoclonal and oligoclonal gammopathy after 2001.
bone marrow transplantation. Blood 74:2764, 1989. 226. Kyle RA: A long-term study of the prognosis in monoclonal gammopathy of undeter-
196. Passweg J, Thiel G, Bock HA: Monoclonal gammopathy after intense induction immu- mined significance. N Engl J Med 346:564, 2002.
nosuppression in renal transplant patients. Nephrol Dial Transplant 11:2461, 1996. 227. Morra E, Cesana C, Klersy C, et al: Clinical characteristics and factors predicting evo-
197. Badley AD, Portela DF, Patel R, et al: Development of monoclonal gammopathy pre- lution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
cedes the development of Epstein-Barr virus-induced posttransplant lymphoprolifera- Leukemia 18:1512, 2004.
tive disorder. Liver Transpl Surg 2:375, 1996. 228. Kyle RA, Therneau TM, Rajkumar SV, et al: Long-term follow-up of IgM monoclonal
198. Touchard G, Pasdeloup T, Parpeix J, et al: High prevalence and usual persistence of gammopathy of undetermined significance. Blood 102:3759, 2003.
serum monoclonal immunoglobulins evidenced by sensitive methods in renal trans- 229. Gregersen H, Mellemkjaer L, Ibsen JS, et al: The impact of M-component type and
plant recipients. Nephrol Dial Transplant 12:1199, 1997. immunoglobulin concentration on risk of malignant transformation in patients with
199. Ho JL, Polde PA, McEniry D, et al: Acquired immunodeficiency syndrome with pro- monoclonal gammopathy of undetermined significance. Haematologica 86:1172, 2001.
gressive multifocal leukoencephalopathy and monoclonal B-cell proliferation. Ann 230. Montoto S, Rozman K, Rosinol L, et al: Malignant transformation in IgM monoclonal
Intern Med 100:693, 1984. gammopathy of undetermined significance. Semin Oncol 30:178, 2003.
200. Nagler A, Ben-Arieh Y, Brenner B, et al: Eosinophilic fibrohistiocytic lesion of bone 231. Van De Donk N, De Weerdt O, Eureling M, et al: Malignant transformation of mono-
marrow associated with monoclonal gammopathy and osteolytic lesions. Am J Hematol clonal gammopathy of undetermined significance: Cumulative incidence and prognos-
23:277, 1986. tic factors. Leuk Lymphoma 42:609, 2001.
201. Hineman VL, Phyliky RL, Banks PM: Angiofollicular lymph node hyperplasia and 232. Cesana C, Klersy C, Barbarano L, et al: Prognostic factors for malignant transformation
peripheral neuropathy: Association with monoclonal gammopathy. Mayo Clin Proc in monoclonal gammopathy of undetermined significance and smoldering multiple
57:379, 1982. myeloma. J Clin Oncol 15:1625, 2002.

Kaushansky_chapter 106_p1721-1732.indd 1730 9/21/15 12:40 PM